One of the companies that could be in focus owing to developments from yesterday is Branded Legacy Inc. (OTC:BLEG). The company’s subsidiary unit, Royal Biotek, was in the news cycle yesterday after it made an announcement with regards to the expansion of its Everglade line of products.
Everglade is a premium cannabis product collection manufactured exclusively for the Surge Distribution Co. In this context, it should be noted that Royal Biotek decided to opt for the expansion due to the initial success enjoyed by Everglade gummies. Additionally, the expansion was also an indication of the considerable achievement that the company had made in its goal of delivering customized cannabis products that could meet the specific needs of the varied clientele of Surge Distribution.
The Chief Executive Officer of Royal Biotek, David Oswald, spoke about the development yesterday. He noted that everyone at the company was thrilled at the prospect of further expansion of the Everglade line with Surge through the launch of THCA Flower. The new product would also feature inventive branding and imagery, which have been integral aspects of the success of the line of products. He went on to note that the addition of the latest product was also a demonstration of the commitment of Royal Biotek to customer satisfaction and strengthened its position as a reliable leader in the premium cannabis space.
As per the provisions of the enhanced partnership with Surge, Royal Biotek would provide 4000 packs of THCA Flore twice in each quarter. It would also generate a steady revenue stream, given that each order is worth around $40,000. The company also revealed that the deal would also lead to considerable growth in the revenues generated by Branded Legacy in the early period of the second fiscal quarter. It could be a good idea to add the stock to your watch lists.
